Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 23, 2021

SELL
$14.52 - $23.53 $383,255 - $621,074
-26,395 Closed
0 $0
Q4 2020

Jan 22, 2021

BUY
$10.14 - $15.19 $6,084 - $9,114
600 Added 2.33%
26,395 $377,000
Q3 2020

Oct 16, 2020

SELL
$9.57 - $21.32 $12,919 - $28,782
-1,350 Reduced 4.97%
25,795 $261,000
Q2 2020

Jul 21, 2020

SELL
$12.21 - $16.99 $16,178 - $22,511
-1,325 Reduced 4.65%
27,145 $400,000
Q1 2020

Apr 16, 2020

SELL
$9.03 - $19.72 $31,604 - $69,020
-3,500 Reduced 10.95%
28,470 $381,000
Q4 2019

Jan 23, 2020

BUY
$13.01 - $17.15 $21,141 - $27,868
1,625 Added 5.36%
31,970 $450,000
Q3 2019

Oct 15, 2019

SELL
$14.55 - $20.56 $5,820 - $8,224
-400 Reduced 1.3%
30,345 $496,000
Q2 2019

Jul 18, 2019

SELL
$15.0 - $19.62 $16,710 - $21,856
-1,114 Reduced 3.5%
30,745 $482,000
Q1 2019

Apr 17, 2019

SELL
$11.65 - $17.72 $3,227 - $4,908
-277 Reduced 0.86%
31,859 $553,000
Q4 2018

Jan 30, 2019

BUY
$10.72 - $16.73 $12,520 - $19,540
1,168 Added 3.77%
32,136 $358,000
Q3 2018

Oct 09, 2018

SELL
$17.73 - $26.69 $100,706 - $151,599
-5,680 Reduced 15.5%
30,968 $756,000
Q2 2018

Jul 16, 2018

SELL
$10.79 - $24.44 $49,774 - $112,741
-4,613 Reduced 11.18%
36,648 $665,000
Q1 2018

Apr 16, 2018

SELL
$9.0 - $20.16 $25,812 - $57,818
-2,868 Reduced 6.5%
41,261 $461,000
Q4 2017

Feb 07, 2018

SELL
$13.26 - $22.86 $31,704 - $54,658
-2,391 Reduced 5.14%
44,129 $857,000
Q3 2017

Nov 01, 2017

BUY
$19.76 - $24.9 $919,235 - $1.16 Million
46,520
46,520 $1.01 Million

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $576M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Nwam LLC Portfolio

Follow Nwam LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nwam LLC with notifications on news.